English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Based on analyzing the status of small and medium-sized pharmaceutical enterprises in China, the paper explores the problems of these enterprises; Then it provided several feasible  development strategies which are building pharmaceutical enterprises' R&D strategic alliance, starting from the corporate strategic view and combining with the R&D characteristics of small and medium sized pharmaceutical companies; Finally in order to ensure the Effectiveness of R & D alliance, we point out some points of what should be noted in the process.</p

Pharmaceutical Enterprises' R&D Strategic Alliance—— the Road for Small and Medium Sized Pharmaceutical Enterprises' R&D in China